{"id":233855,"date":"2025-12-23T00:00:00","date_gmt":"2025-12-23T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041124-medtech-interventional-oncology-devices-market-insights\/"},"modified":"2026-04-14T10:02:28","modified_gmt":"2026-04-14T10:02:28","slug":"47042585-medtech-interventional-oncology-devices-market-insights-united-states","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042585-medtech-interventional-oncology-devices-market-insights-united-states\/","title":{"rendered":"Interventional Oncology Devices &#8211; Market Insights &#8211; United States"},"content":{"rendered":"<p>The US market for interventional oncology devices will be driven by the launch and uptake of higher-priced technologies, favorable clinical data, expanding populations that are treatable with ablation, and updates to clinical guidelines.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the US from 2019 through 2034.<\/p>\n<p class=\"question-statement\"><strong>The launch of innovative ablation technologies is reshaping the ablation device market.<\/strong><\/p>\n<p class=\"question-statement\"><!--StartFragment -->Which companies are leading in innovation, and how are their device designs impacting clinical uptake?<!--EndFragment --><\/p>\n<p class=\"question-statement\">How does <abbr data-abbreviation-entity=\"9803\" title=\"Irreversible Electroporation\">IRE<\/abbr> compare to other available treatments? <!--EndFragment --><\/p>\n<p class=\"question-statement\"><!--StartFragment --><\/p>\n<p class=\"question-statement\"><strong>The adoption rates of different ablation modalities have shifted in recent years.<\/strong><\/p>\n<p>How will growth vary across different ablation device categories?<\/p>\n<p>In which indications and how strongly are cryoablation and <abbr title=\"Irreversible Electroporation\">IRE<\/abbr> ablation being adopted?<\/p>\n<p>What are the key ongoing clinical trials related to ablation, and what implications might they have for the interventional oncology device market?<\/p>\n<p><strong>Newer embolization technologies are seeing increasing adoption.<\/strong><\/p>\n<p>How will the adoption of radioembolization spheres be affected by recent clinical trials and upcoming products?<\/p>\n<p>What is the adoption outlook for different embolization devices, and what factors will affect the uptake of these technologies over the forecast period?<\/p>\n<p>What impact will clinical guidance have on the adoption of newer technologies in the embolization device market?<\/p>\n","protected":false},"template":"","class_list":["post-233855","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-interventional-oncology-devices","medtech-therapy-area-other-medical-technology","medtech-geography-united-states","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":3,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233855\/revisions"}],"predecessor-version":[{"id":571867,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233855\/revisions\/571867"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=233855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}